Please Wait.....
Report
Europe E-Pharmacy Market - Industry Outlook & Forecast 2023-2028
Market Report I 2023-08-08 I 273 Pages I Arizton Advisory & Intelligence
The Europe e-pharmacy market is expected to grow at a CAGR of 17.65% from 2022 to 2028.
MARKET TRENDS & OPPORTUNITIES
Rapidly Growing E-Health & E-prescription
Due to the progressive nature of healthcare and medicine deliveries in Europe, the approach changing from hospital care to homecare deliveries offers huge opportunities in European patient management across all healthcare systems. Growing adoption of e-health solutions such as m-health, telemedicine, and e-prescription help consumers connect directly to health professionals and receive care and consultations at home. Increasing use of e-health applications and increasing allowance to e-prescription drive the high medicine purchasing orders through e-pharmacies that have recently accelerated the Europe e-pharmacy market growth.
Integration of AI, & IoT
Technologies such as artificial intelligence (AI), Machine Learning, and the Internet of Things can make pharmacy technologies more powerful. Europe is a technology-driven market for healthcare systems and pharmaceutical industries. Pharmacies with AI, Machine Learning, offer multiple benefits, such as data processing, enabling pharmacists to make quick data-backed decisions and improve customer services. Furthermore, with IoT, drug inventory management will be faster and more accurate; through device-to-device communication. To accelerate performance advancement, pharmacists must be skilled at using emerging technologies of all kinds.
Strategic Operations for Market Expansion by Vendors
The European e-pharmacy market is witnessing massive development with several business strategies implementation. Several strategic partnerships, collaborations, and mergers & acquisitions have been registered in the Europe e-pharmacy market in recent years. Some leading industry players are considering strategic and opportunistic acquisitions of other companies, businesses, or assets. In 2023, the leading industry player SHOP APOTHEKE EUROPE and Galenica entered a strategic partnership and established MediService Ltd leading online pharmacy in Switzerland.
SEGMENTATION INSIGHTS
INSIGHTS BY MEDICINE TYPE
The Europe e-pharmacy market by medicine type is segmented into over-the-counter (OTC) and prescription. OTC medicine types, including health & wellness and nutrition, dietary supplements, personal care, and cosmetic care solutions, are commonly and majorly ordered by people. The OTC segment accounted for the largest segmental revenue share in 2022. In Europe, most countries experienced a high demand for OTC products. In 2018, Roblek et al. found that customer expresses three typical online behaviors of OTC drugs: searching for information about OTC medicines without any particular purpose, buying OTC medicines, and searching for products or information.
Segmentation by Medicine Type
- OTC
- Prescription
INSIGHTS BY PLATFORM
The mobile platform segment accounted for the largest revenue share in the Europe e-pharmacy market in 2022. The increasing prevalence of chronic diseases drives awareness about medications and therapies in developed countries such as Germany, France, Switzerland, Italy, the UK, Spain, and others witnessed increasing use of mobile devices and associated applications to buy medicines online. Online pharmacies are witnessing the high growth and demand for medicines through smartphones and tablets.
Segmentation by Platform
- Mobile
- Desktop
INSIGHTS BY AGE GROUP
The below-50 age group segment dominated the Europe e-pharmacy market share in 2022. The below-50 age group highly uses internet services & smartphones and highly prefers buying medicine from online pharmacies. The penetration of e-commerce shopping preference accelerates the higher segmental growth.
Segmentation by Age Group
- Below 50
- Above 50
INSIGHTS BY PRODUCT
The Europe e-pharmacy market by product types includes medications, health & wellness and nutrition, personal care & essentials, and others. The medications segment accounted for the industry's highest revenue share of over 75% in 2022. Online pharmacies purchase mostly prescription drugs associated with viral infections such as cold and flu, cough, diabetes-associated drugs, cancer care drugs, etc. On another side, opioids, slimming tablets, and hypnotic and sedative agents are some of the prescription medicines highly sold in Europe.
Segmentation by Product
- Medications
- Health & Wellness and Nutrition
- Personal Care & Essentials
- Others
REGIONAL ANALYSIS
EU-4 & UK is a major region in the Europe e-pharmacy market with high development in the pharmaceutical industry, research and development, production, sale, marketing, and distribution. The huge patient population and higher patient health expenditures are accelerating the application rate of e-pharmacy websites and mobile applications. In 2022, EU-4 & UK region accounted for the highest share of over 59% in the Europe e-pharmacy market. In EU-4 & UK region, major countries such as Germany and the UK have made major progress in the e-pharmacy network. The presence of major and emerging e-pharmacies accelerates regional growth. On another side, the growing patient population and rising expenditure on health propelling regional growth. Furthermore, Italy and Spain have shown rapid growth in e-pharmacies.
Segmentation by Geography
- EU-4 & UK
o Germany
o UK
o France
o Italy
o Spain
- Central and Eastern Europe
o Poland
o Netherlands
o Russia
o Switzerland
o Czech Republic
- Nordic Countries
o Denmark
o Sweden
o Norway
o Finland
o Iceland
VENDOR LANDSCAPE
In the Europe e-pharmacy market, several local/traditional/offline and online pharmacies are present in the region, significantly driving the competitive rivalry. In addition, the access to e-commerce channels and their involvement in medication deliveries make the European e-pharmacy market highly competitive. The e-commerce channels allow European pharmacies to provide/offer a wider range of products than local pharmacies, not constrained by the amount of physical shelf storage space.
Key Company Profiles
- DocMorris AG (Zur Rose Group)
- Shop Apotheke
Other Prominent Vendors
- AMX Holdings
- Apteka.ru
- Apotea
- Apoteket
- AZETA
- BestPharmacy
- Chemist4U
- Chemist Direct
- Cocooncenter
- DeOnlineDrogist
- ePharmacy (EAPTEKA)
- Euro-Pharmas
- Express Pharmacy
- EVERER GmbH
- Farmacia Internacional
- Helsinki University Pharmacy [Yliopiston Apteekki] (YA)
- Index Medical
- INHOUSE PHARMACY
- Juvalis
- Lekarna WPK
- Lloyds Pharmacy
- Lekarnar
- Lyf og heilsa hf.
- Lyfjaver
- MedExpress Enterprises
- MonCoinSante
- Mistletoe Pharmacy
- myCARE
- MediService AG
- Mediservice Ltd
- MEDS
- Newpharma
- Oxford Online Pharmacy
- Prvalekarna
- Parafarmacia-online
- Pharmacy2U
- Pharmacy Direct GB
- Pharm24
- PROTEK Group
- SBER EAPTEKA
- Simple Online Pharmacy
- The independent pharmacy
- The French pharmacy
- UK Meds Direct
- WebMed Pharmacy
- Pharmacy4u
- Vamida
KEY QUESTIONS ANSWERED:
1. How big is the Europe e-pharmacy market?
2. What is the growth rate of the Europe e-pharmacy market?
3. What are the growing trends in the Europe e-pharmacy market?
4. Which region holds the most significant Europe e-pharmacy market share?
5. Who are the key players in the Europe e-pharmacy market?
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY MEDICINE TYPE
4.3.2 MARKET SEGMENTATION BY PLATFORM
4.3.3 MARKET SEGMENTATION BY PRODUCT TYPE
4.3.4 MARKET SEGMENTATION BY AGE GROUP
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 PREMIUM INSIGHTS
6.1 OVERVIEW
7 MARKET AT A GLANCE
8 INTRODUCTION
8.1 OVERVIEW
8.1.1 EUROPE E-PHARMACY MARKET OUTLOOK
8.1.2 GLOBAL E-PHARMACY MARKET OUTLOOK
9 MARKET OPPORTUNITIES & TRENDS
9.1 INCREASED E-HEALTH & E-PRESCRIPTION SERVICES
9.2 INTEGRATION OF ARTIFICIAL INTELLIGENCE & INTERNET OF THINGS
9.3 STRATEGIC ACQUISITIONS FOR MARKET EXPANSION
9.4 INTEGRATION OF E-PHARMACIES WITH DELIVERY MANAGEMENT SOLUTIONS
10 MARKET GROWTH ENABLERS
10.1 INTERNET PENETRATION AMONG PATIENT POPULATION
10.2 INCREASED HOME HEALTHCARE DELIVERIES
10.3 INCREASED HEALTH AWARENESS & SELF-MEDICATION
10.4 INCREASED PATIENT POPULATION
11 MARKET RESTRAINTS
11.1 STRINGENT REGULATORY NORMS
11.2 DATA BREACH & PRIVACY ISSUES
11.3 COMPETITION FROM TRADITIONAL PHARMACIES
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.1.1 MARKET BY MEDICINE TYPE
12.1.2 MARKET BY PLATFORM
12.1.3 MARKET BY AGE GROUP
12.1.4 MARKET BY PRODUCT TYPE
12.1.5 MARKET BY REGION
12.2 MARKET SIZE & FORECAST
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 MEDICINE TYPE
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 OTC
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 MARKET BY GEOGRAPHY
13.4 RX
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
14 PLATFORM
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 MOBILE
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 DESKTOP
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
15 AGE GROUP
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 BELOW 50
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 ABOVE 50
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
16 PRODUCT TYPE
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 MEDICATION
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.3.3 MARKET BY GEOGRAPHY
16.4 HEALTH, WELLNESS & NUTRITION
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.4.3 MARKET BY GEOGRAPHY
16.5 PERSONAL CARE & ESSENTIALS
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.5.3 MARKET BY GEOGRAPHY
16.6 OTHERS
16.6.1 MARKET OVERVIEW
16.6.2 MARKET SIZE & FORECAST
16.6.3 MARKET BY GEOGRAPHY
17 REGION
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 REGIONAL OVERVIEW
18 EU-4 & UK
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 MEDICINE TYPE
18.3.1 MARKET SIZE & FORECAST
18.4 PLATFORM
18.4.1 MARKET SIZE & FORECAST
18.5 AGE GROUP
18.5.1 MARKET SIZE & FORECAST
18.6 PRODUCT TYPE
18.6.1 MARKET SIZE & FORECAST
18.7 KEY COUNTRIES
18.7.1 GERMANY: MARKET SIZE & FORECAST
18.7.2 UK: MARKET SIZE & FORECAST
18.7.3 FRANCE: MARKET SIZE & FORECAST
18.7.4 ITALY: MARKET SIZE & FORECAST
18.7.5 SPAIN: MARKET SIZE & FORECAST
19 CENTRAL & EASTERN EUROPE
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 MEDICINE TYPE
19.3.1 MARKET SIZE & FORECAST
19.4 PLATFORM
19.4.1 MARKET SIZE & FORECAST
19.5 AGE GROUP
19.5.1 MARKET SIZE & FORECAST
19.6 PRODUCT TYPE
19.6.1 MARKET SIZE & FORECAST
19.7 KEY COUNTRIES
19.7.1 POLAND: MARKET SIZE & FORECAST
19.7.2 NETHERLANDS: MARKET SIZE & FORECAST
19.7.3 RUSSIA: MARKET SIZE & FORECAST
19.7.4 SWITZERLAND: MARKET SIZE & FORECAST
19.7.5 CZECH REPUBLIC: MARKET SIZE & FORECAST
20 NORDIC COUNTRIES
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 MEDICINE TYPE
20.3.1 MARKET SIZE & FORECAST
20.4 PLATFORM
20.4.1 MARKET SIZE & FORECAST
20.5 AGE GROUP
20.5.1 MARKET SIZE & FORECAST
20.6 PRODUCT TYPE
20.6.1 MARKET SIZE & FORECAST
20.7 KEY COUNTRIES
20.7.1 DENMARK: MARKET SIZE & FORECAST
20.7.2 SWEDEN: MARKET SIZE & FORECAST
20.7.3 NORWAY: MARKET SIZE & FORECAST
20.7.4 FINLAND: MARKET SIZE & FORECAST
20.7.5 ICELAND: MARKET SIZE & FORECAST
21 COMPETITIVE LANDSCAPE
21.1 COMPETITION OVERVIEW
21.2 MARKET SHARE ANALYSIS
22 KEY COMPANY PROFILES
22.1 DOCMORRIS AG (ZUR ROSE GROUP)
22.1.1 BUSINESS OVERVIEW
22.1.2 KEY STRATEGIES
22.1.3 KEY STRENGTHS
22.1.4 KEY OPPORTUNITIES
22.2 SHOP APOTHEKE
22.2.1 BUSINESS OVERVIEW
22.2.2 KEY STRATEGIES
22.2.3 KEY STRENGTHS
22.2.4 KEY OPPORTUNITIES
23 OTHER PROMINENT VENDORS
23.1 AMX HOLDINGS
23.1.1 BUSINESS OVERVIEW
23.1.2 KEY STRATEGIES
23.1.3 KEY STRENGTHS
23.2 APTEKA.RU
23.2.1 BUSINESS OVERVIEW
23.2.2 KEY STRATEGIES
23.2.3 KEY STRENGTHS
23.3 APOTEA
23.3.1 BUSINESS OVERVIEW
23.3.2 KEY STRATEGIES
23.3.3 KEY STRENGTHS
23.4 APOTEKET
23.4.1 BUSINESS OVERVIEW
23.4.2 KEY STRATEGIES
23.4.3 KEY STRENGTHS
23.5 AZETA
23.5.1 BUSINESS OVERVIEW
23.5.2 KEY STRATEGIES
23.5.3 KEY STRENGTHS
23.6 BESTPHARMACY
23.6.1 BUSINESS OVERVIEW
23.6.2 KEY STRATEGIES
23.6.3 KEY STRENGTHS
23.7 CHEMIST4U
23.7.1 BUSINESS OVERVIEW
23.7.2 KEY STRATEGIES
23.7.3 KEY STRENGTHS
23.8 CHEMIST DIRECT
23.8.1 BUSINESS OVERVIEW
23.8.2 KEY STRATEGIES
23.8.3 KEY STRENGTHS
23.9 COCOONCENTER
23.9.1 BUSINESS OVERVIEW
23.9.2 KEY STRATEGIES
23.9.3 KEY STRENGTHS
23.10 DEONLINEDROGIST
23.10.1 BUSINESS OVERVIEW
23.10.2 KEY STRATEGIES
23.10.3 KEY STRENGTHS
23.11 EPHARMACY (EAPTEKA)
23.11.1 BUSINESS OVERVIEW
23.11.2 KEY STRATEGIES
23.11.3 KEY STRENGTHS
23.12 EURO-PHARAMAS
23.12.1 BUSINESS OVERVIEW
23.12.2 KEY STRATEGIES
23.12.3 KEY STRENGTHS
23.13 EXPRESS PHARMACY
23.13.1 BUSINESS OVERVIEW
23.13.2 KEY STRATEGIES
23.13.3 KEY STRENGTHS
23.14 EVERER GMBH
23.14.1 BUSINESS OVERVIEW
23.14.2 KEY STRATEGIES
23.14.3 KEY STRENGTHS
23.15 FRAMACIA INTERNACIONAL
23.15.1 BUSINESS OVERVIEW
23.15.2 KEY STRATEGIES
23.15.3 KEY STRENGTHS
23.16 HELSINKI UNIVERSITY PHARMACY [YLIOPISTAN APTEEKKI] (YA)
23.16.1 BUSINESS OVERVIEW
23.16.2 KEY STRATEGIES
23.16.3 KEY STRENGTHS
23.17 INDEX MEDICAL
23.17.1 BUSINESS OVERVIEW
23.17.2 KEY STRATEGIES
23.17.3 KEY STRENGTHS
23.18 INHOUSE PHARMACY
23.18.1 BUSINESS OVERVIEW
23.18.2 KEY STRATEGIES
23.18.3 KEY STRENGTHS
23.19 JUVALIS
23.19.1 BUSINESS OVERVIEW
23.19.2 KEY STRATEGIES
23.19.3 KEY STRENGTHS
23.20 LEKARNA WPK
23.20.1 BUSINESS OVERVIEW
23.20.2 KEY STRATEGIES
23.20.3 KEY STRENGTHS
23.21 LLOYDS PHARMACY
23.21.1 BUSINESS OVERVIEW
23.21.2 KEY STRATEGIES
23.21.3 KEY STRENGTHS
23.22 LEKARNAR
23.22.1 BUSINESS OVERVIEW
23.22.2 KEY STRATEGIES
23.22.3 KEY STRENGTHS
23.23 LYF OG HEILSA
23.23.1 BUSINESS OVERVIEW
23.23.2 KEY STRATEGIES
23.23.3 KEY STRENGTHS
23.24 LYFJAVER
23.24.1 BUSINESS OVERVIEW
23.24.2 KEY STRATEGIES
23.24.3 KEY STRENGTHS
23.25 MEDEXPRESS ENTERPRISES
23.25.1 BUSINESS OVERVIEW
23.25.2 KEY STRATEGIES
23.25.3 KEY STRENGTHS
23.26 MONCOINSANTE
23.26.1 BUSINESS OVERVIEW
23.26.2 KEY STRATEGIES
23.26.3 KEY STRENGTHS
23.27 MISTLETOE PHARMACY
23.27.1 BUSINESS OVERVIEW
23.27.2 KEY STRATEGIES
23.27.3 KEY STRENGTHS
23.28 MYCARE
23.28.1 BUSINESS OVERVIEW
23.28.2 KEY STRATEGIES
23.28.3 KEY STRENGTHS
23.29 MEDISERVICE AG
23.29.1 BUSINESS OVERVIEW
23.29.2 KEY STRATEGIES
23.29.3 KEY STRENGTHS
23.30 MEDSERVICE LTD
23.30.1 BUSINESS OVERVIEW
23.30.2 KEY STRATEGIES
23.30.3 KEY STRENGTHS
23.31 MEDS
23.31.1 BUSINESS OVERVIEW
23.31.2 KEY STRATEGIES
23.31.3 KEY STRENGTHS
23.32 NEWPHARMA
23.32.1 BUSINESS OVERVIEW
23.32.2 KEY STRATEGIES
23.32.3 KEY STRENGTHS
23.33 OXFORD ONLINE PHARMACY
23.33.1 BUSINESS OVERVIEW
23.33.2 KEY STRATEGIES
23.33.3 KEY STRENGTHS
23.34 PRVALEKARNA
23.34.1 BUSINESS OVERVIEW
23.34.2 KEY STRATEGIES
23.34.3 KEY STRENGTHS
23.35 PARAFARMACIA-ONLINE
23.35.1 BUSINESS OVERVIEW
23.35.2 KEY STRATEGIES
23.35.3 KEY STRENGTHS
23.36 PHARMACY2U
23.36.1 BUSINESS OVERVIEW
23.36.2 KEY STRATEGIES
23.36.3 KEY STRENGTHS
23.37 PHARMACY DIRECT GB
23.37.1 BUSINESS OVERVIEW
23.37.2 KEY STRATEGIES
23.37.3 KEY STRENGTHS
23.38 PHARMA24
23.38.1 BUSINESS OVERVIEW
23.38.2 KEY STRATEGIES
23.38.3 KEY STRENGTHS
23.39 PROTEK GROUP
23.39.1 BUSINESS OVERVIEW
23.39.2 KEY STRATEGIES
23.39.3 KEY STRENGTHS
23.40 SBER EAPTEKA
23.40.1 BUSINESS OVERVIEW
23.40.2 KEY STRATEGIES
23.40.3 KEY STRENGTHS
23.41 SIMPLE ONLINE PHARMACY
23.41.1 BUSINESS OVERVIEW
23.41.2 KEY STRATEGIES
23.41.3 KEY STRENGTHS
23.42 THE INDEPENDENT PHARMACY
23.42.1 BUSINESS OVERVIEW
23.42.2 KEY STRATEGIES
23.42.3 KEY STRENGTHS
23.43 THE FRENCH PHARMACY
23.43.1 BUSINESS OVERVIEW
23.43.2 KEY STRATEGIES
23.43.3 KEY STRENGTHS
23.44 UK MEDS DIRECT
23.44.1 BUSINESS OVERVIEW
23.44.2 KEY STRATEGIES
23.44.3 KEY STRENGTHS
23.45 WEBMED PHARMACY
23.45.1 BUSINESS OVERVIEW
23.45.2 KEY STRATEGIES
23.45.3 KEY STRENGTHS
23.46 PHARMACY4U
23.46.1 BUSINESS OVERVIEW
23.46.2 KEY STRATEGIES
23.46.3 KEY STRENGTHS
23.47 VAMIDA
23.47.1 BUSINESS OVERVIEW
23.47.2 KEY STRATEGIES
23.47.3 KEY STRENGTHS
24 REPORT SUMMARY
24.1 KEY TAKEAWAYS
24.2 STRATEGIC RECOMMENDATIONS
25 QUANTITATIVE SUMMARY
25.1 MARKET BY REGION
25.2 MARKET BY MEDICINE TYPE
25.3 MARKET BY PLATFORM
25.4 MARKET BY AGE GROUP
25.5 MARKET BY PRODUCT TYPE
25.6 EU-4 & UK: MARKET SEGMENTATION
25.6.1 EU-4 & UK E-PHARMACY MARKET BY MEDICINE TYPE
25.6.2 EU-4 & UK E-PHARMACY MARKET BY PLATFORM
25.6.3 EU-4 & UK E-PHARMACY MARKET BY AGE GROUP
25.6.4 EU-4 & UK E-PHARMACY MARKET BY PRODUCT TYPE
25.7 CENTRAL & EASTERN EUROPE: MARKET SEGMENTATION
25.7.1 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY MEDICINE TYPE
25.7.2 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PLATFORM
25.7.3 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY AGE GROUP
25.7.4 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PRODUCT TYPE
25.8 NORDIC COUNTRIES: MARKET SEGMENTATION
25.8.1 NORDIC COUNTRIES E-PHARMACY MARKET BY MEDICINE TYPE
25.8.2 NORDIC COUNTRIES E-PHARMACY MARKET BY PLATFORM
25.8.3 NORDIC COUNTRIES E-PHARMACY MARKET BY AGE GROUP
25.8.4 NORDIC COUNTRIES E-PHARMACY MARKET BY PRODUCT TYPE
26 APPENDIX
26.1 ABBREVIATIONS
LIST OF EXHIBITS
EXHIBIT 1 SEGMENTATION OF EUROPE E-PHARMACY MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022
EXHIBIT 3 EUROPE E-PHARMACY MARKET DYNAMICS (2022)
EXHIBIT 4 IMPACT OF INCREASED E-HEALTH & E-PRESCRIPTION SERVICES
EXHIBIT 5 IMPACT OF INTEGRATION OF ARTIFICIAL INTELLIGENCE & INTERNET OF THINGS
EXHIBIT 6 AI IN E-PHARMACY
EXHIBIT 7 IMPACT OF STRATEGIC ACQUISITIONS FOR MARKET EXPANSION
EXHIBIT 8 IMPACT OF INTEGRATION OF E-PHARMACIES WITH DELIVERY MANAGEMENT SOLUTIONS
EXHIBIT 9 SERVICES OFFERED BY PHARMACY DELIVERY SOFTWARE SOLUTIONS
EXHIBIT 10 IMPACT OF INTERNET PENETRATION AMONG PATIENT POPULATION
EXHIBIT 11 INTERNET USE IN EUROPE
EXHIBIT 12 EUROPEAN COUNTRIES WITH INTERNET USE & ONLINE PURCHASE ATTITUDE (2023)
EXHIBIT 13 IMPACT OF INCREASED HOME HEALTHCARE DELIVERIES
EXHIBIT 14 ADVANTAGES OF E-PHARMACIES IN HOMECARE SETTINGS
EXHIBIT 15 IMPACT OF INCREASED HEALTH AWARENESS & SELF-MEDICATION
EXHIBIT 16 IMPACT OF INCREASED PATIENT POPULATION
EXHIBIT 17 PEOPLE AGED 65 & ABOVE WITH CHRONIC DISEASE PREVALENCE BY COUNTRY (%): 2018
EXHIBIT 18 IMPACT OF STRINGENT REGULATORY NORMS
EXHIBIT 19 IMPACT OF DATA BREACH & PRIVACY ISSUES
EXHIBIT 20 IMPACT OF COMPETITION FROM TRADITIONAL PHARMACIES
EXHIBIT 21 EUROPE E-PHARMACY MARKET BY MEDICINE TYPE: MARKET SHARE 2022 & 2028
EXHIBIT 22 EUROPE E-PHARMACY MARKET BY PLATFORM: MARKET SHARE 2022 & 2028
EXHIBIT 23 EUROPE E-PHARMACY MARKET BY AGE GROUP: MARKET SHARE 2022 & 2028
EXHIBIT 24 EUROPE E-PHARMACY MARKET BY PRODUCT TYPE: MARKET SHARE 2022 & 2028
EXHIBIT 25 EUROPE E-PHARMACY MARKET BY REGION: MARKET SHARE 2022 & 2028
EXHIBIT 26 EUROPE E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 27 FIVE FORCES ANALYSIS 2022
EXHIBIT 28 INCREMENTAL GROWTH BY MEDICINE TYPE 2022 & 2028
EXHIBIT 29 EUROPE E-PHARMACY MARKET BY MEDICINE TYPE 2022-2028
EXHIBIT 30 EUROPE E-PHARMACY MARKET BY MEDICINE TYPE: SEGMENTAL OVERVIEW
EXHIBIT 31 COUNTRIES THAT ALLOW PRESCRIPTION & NON-PRESCRIPTION/OTC PRODUCT SALES THROUGH E-PHARMACIES
EXHIBIT 32 EUROPE E-PHARMACY MARKET BY MEDICINE TYPE: INCREMENTAL GROWTH
EXHIBIT 33 EUROPE E-PHARMACY MARKET BY MEDICINE TYPE: ABSOLUTE GROWTH
EXHIBIT 34 EUROPE OTC E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 35 EUROPE OTC E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 36 EUROPE RX E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 37 EUROPE RX E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 38 INCREMENTAL GROWTH BY PLATFORM 2022 & 2028
EXHIBIT 39 EUROPE E-PHARMACY MARKET BY PLATFORM 2022-2028
EXHIBIT 40 EUROPE E-PHARMACY MARKET BY PLATFORM: SEGMENTAL OVERVIEW
EXHIBIT 41 EUROPE E-PHARMACY MARKET BY PLATFORM: INCREMENTAL GROWTH
EXHIBIT 42 EUROPE MOBILE E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 43 EUROPE MOBILE E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 44 PERSONAL COMPUTER PENETRATION PER CAPITA IN WESTERN EUROPE (2014-2019)
EXHIBIT 45 DESKTOP PENETRATION IN THE UK (2015-2020)
EXHIBIT 46 EUROPE DESKTOP E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 47 EUROPE DESKTOP E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 48 INCREMENTAL GROWTH BY AGE GROUP 2022 & 2028
EXHIBIT 49 EUROPE E-PHARMACY MARKET BY AGE GROUP 2022-2028
EXHIBIT 50 THE EUROPE E-PHARMACY MARKET BY AGE GROUP SEGMENT: SEGMENTAL OVERVIEW
EXHIBIT 51 EUROPE E-PHARMACY MARKET BY AGE GROUP: INCREMENTAL GROWTH
EXHIBIT 52 EUROPE E-PHARMACY MARKET BY AGE GROUP: ABSOLUTE GROWTH
EXHIBIT 53 EUROPE BELOW 50 E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 54 INTERNET USERS IN EUROPE BY AGE GROUP WHO BOUGHT/ORDERED GOODS & SERVICES ONLINE (2010-2022) (%)
EXHIBIT 55 POLAND E-PHARMACY VISITS BY AGE GROUP (2016)
EXHIBIT 56 EUROPE BELOW 50 E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 57 INTERNET USERS IN EUROPE BY AGE GROUP WHO ORDERED GOODS & SERVICES THROUGH E-COMMERCE WEBSITES: 2010 TO 2022 (%)
EXHIBIT 58 POLAND ONLINE PHARMACY VISITS BY AGE GROUP 2016
EXHIBIT 59 EUROPE ABOVE 50 E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 60 EUROPE ABOVE 50 E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 61 INCREMENTAL GROWTH BY PRODUCT TYPE 2022 & 2028
EXHIBIT 62 EUROPE E-PHARMACY MARKET BY PRODUCT TYPE 2022-2028
EXHIBIT 63 EUROPE E-PHARMACY MARKET BY PRODUCT TYPE: SEGMENTAL OVERVIEW
EXHIBIT 64 EUROPE E-COMMERCE PURCHASE BY PRODUCT CATEGORY: 2021 (%)
EXHIBIT 65 EUROPE E-PHARMACY MARKET BY PRODUCT TYPE: INCREMENTAL GROWTH
EXHIBIT 66 EUROPE E-PHARMACY MARKET BY PRODUCT TYPE: ABSOLUTE GROWTH
EXHIBIT 67 PURCHASED MEDICATION PREFERENCE THROUGH E-PHARMACIES
EXHIBIT 68 EUROPE MEDICATION E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 69 EUROPE MEDICATION E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 70 TOP 10 NUTRITIONAL SUPPLEMENTS CONSUMED BY EUROPEANS (2022)
EXHIBIT 71 EUROPE HEALTH, WELLNESS & NUTRITION E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 72 EUROPE HEALTH, WELLNESS & NUTRITION E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 73 EUROPE PERSONAL CARE & COSMETIC PRODUCT EXPENDITURE: 2021 (BILLION)
EXHIBIT 74 EUROPE PERSONAL CARE & ESSENTIALS E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 75 EUROPE PERSONAL CARE & ESSENTIALS E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 76 EUROPE OTHERS E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 77 EUROPE OTHERS E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 78 INCREMENTAL GROWTH BY REGION 2022 & 2028
EXHIBIT 79 EUROPE E-PHARMACY MARKET BY REGION 2022-2028
EXHIBIT 80 INTERNET USERS & E-SHOPPERS IN EU-4 & UK (2021)
EXHIBIT 81 COUNTRIES THAT ALLOW PRESCRIPTION & NON-PRESCRIPTION/OTC PRODUCT SALES THROUGH ONLINE PHARMACIES
EXHIBIT 82 EU-4 & UK E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 83 EU-4 & UK E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 84 INCREMENTAL GROWTH IN EU-4 & UK 2022 & 2028
EXHIBIT 85 SEARCH FOR E-PHARMACIES IN GERMANY: JANUARY 2020 TO JANUARY 2021 (%)
EXHIBIT 86 GERMANY E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 87 UK E-PRESCRIPTION STATISTICS (2019)
EXHIBIT 88 UK E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 89 NON-PRESCRIPTION MEDICINE SALES THROUGH E-PHARMACIES: ONLINE DRUGS SALES REGULATION
EXHIBIT 90 WILLINGNESS TO PURCHASE MEDICINES ONLINE: FRANCE
EXHIBIT 91 FRANCE E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 92 OPINION ABOUT ONLINE SALE OF MEDICINES IN ITALY (2019)
EXHIBIT 93 ITALY E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 94 SPAIN E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 95 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 96 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 97 INCREMENTAL GROWTH IN CENTRAL & EASTERN EUROPE 2022 & 2028
EXHIBIT 98 POLAND E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 99 NETHERLANDS FACTS (2020)
EXHIBIT 100 NETHERLANDS E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 101 RUSSIA E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 102 SWITZERLAND E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 103 INTERNET PENETRATION: CZECH REPUBLIC (2021)
EXHIBIT 104 CZECH REPUBLIC E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 105 NORDIC COUNTRIES E-PHARMACY MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
EXHIBIT 106 NORDIC COUNTRIES E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 107 INCREMENTAL GROWTH IN NORDIC COUNTRIES 2022 & 2028
EXHIBIT 108 DENMARK: ALLOCATION OF DIFFERENT ENTITIES OF PHARMACIES (2020)
EXHIBIT 109 DENMARK E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 110 SWEDEN PHARMACY & E-PHARMACY STATISTICS (2022)
EXHIBIT 111 SWEDEN E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 112 NORWAY E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 113 FINLAND E-PHARMACY MARKET 2022-2028 ($ BILLION)
EXHIBIT 114 ICELAND E-PHARMACY MARKET 2022-2028 ($ BILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2016-2022
TABLE 3 E-PRESCRIPTION GENERATION IN EUROPEAN COUNTRIES
TABLE 4 EUROPE E-PHARMACY MARKET: STRATEGIC PARTNERSHIPS, M&A & COLLABORATIONS
TABLE 5 SELF-MEDICATION PREVALENCE BY THERAPY AREAS IN EUROPEAN COUNTRIES (2020)
TABLE 6 DATA BREACHING & CYBERATTACK ISSUES
TABLE 7 EUROPE E-PHARMACY MARKET: SEGMENTAL DATA COMPARISON (2022-2028)
TABLE 8 EUROPE OTC E-PHARMACY MARKET BY REGION 2022-2028 ($ BILLION)
TABLE 9 EUROPE OTC E-PHARMACY MARKET BY REGION 2022-2028 (%)
TABLE 10 EUROPE RX E-PHARMACY MARKET BY REGION 2022-2028 ($ BILLION)
TABLE 11 EUROPE RX E-PHARMACY MARKET BY REGION 2022-2028 (%)
TABLE 12 EUROPE SMARTPHONE PENETRATION & USERS (2021)
TABLE 13 EUROPE MOBILE E-PHARMACY MARKET BY REGION 2022-2028 ($ BILLION)
TABLE 14 EUROPE MOBILE E-PHARMACY MARKET BY REGION 2022-2028 (%)
TABLE 15 EUROPE DESKTOP E-PHARMACY MARKET BY REGION 2022-2028 ($ BILLION)
TABLE 16 EUROPE DESKTOP E-PHARMACY MARKET BY REGION 2022-2028 (%)
TABLE 17 RESPONDENTS WHO PURCHASED MEDICINE THROUGH ONLINE PHARMACIES IN EUROPE (2021)
TABLE 18 EUROPE BELOW 50 E-PHARMACY MARKET BY REGION 2022-2028 ($ BILLION)
TABLE 19 EUROPE BELOW 50 E-PHARMACY MARKET BY REGION 2022-2028 (%)
TABLE 20 RESPONDENTS WHO PURCHASED MEDICINE FROM ONLINE PHARMACIES IN EUROPE (2021)
TABLE 21 EUROPE ABOVE 50 E-PHARMACY MARKET BY REGION 2022-2028 ($ BILLION)
TABLE 22 EUROPE ABOVE 50 E-PHARMACY MARKET BY REGION 2022-2028 (%)
TABLE 23 EUROPE MEDICATION E-PHARMACY MARKET BY REGION 2022-2028 ($ BILLION)
TABLE 24 EUROPE MEDICATION E-PHARMACY MARKET BY REGION 2022-2028 (%)
TABLE 25 EUROPE HEALTH, WELLNESS & NUTRITION E-PHARMACY MARKET BY REGION 2022-2028 ($ BILLION)
TABLE 26 EUROPE HEALTH, WELLNESS & NUTRITION E-PHARMACY MARKET BY REGION 2022-2028 (%)
TABLE 27 EUROPE PERSONAL CARE & ESSENTIALS E-PHARMACY MARKET BY REGION 2022-2028 ($ BILLION)
TABLE 28 EUROPE PERSONAL CARE & ESSENTIALS E-PHARMACY MARKET BY REGION 2022-2028 (%)
TABLE 29 EUROPE OTHERS E-PHARMACY MARKET BY REGION 2022-2028 ($ BILLION)
TABLE 30 EUROPE OTHERS E-PHARMACY MARKET BY REGION 2022-2028 (%)
TABLE 31 EU-4 & UK E-PHARMACY MARKET BY MEDICINE TYPE 2022-2028 ($ BILLION)
TABLE 32 EU-4 & UK E-PHARMACY MARKET BY MEDICINE TYPE 2022-2028 (%)
TABLE 33 EU-4 & UK E-PHARMACY MARKET BY PLATFORM 2022-2028 ($ BILLION)
TABLE 34 EU-4 & UK E-PHARMACY MARKET BY PLATFORM 2022-2028 (%)
TABLE 35 EU-4 & UK E-PHARMACY MARKET BY AGE GROUP 2022-2028 ($ BILLION)
TABLE 36 EU-4 & UK E-PHARMACY MARKET BY AGE GROUP 2022-2028 (%)
TABLE 37 EU-4 & UK E-PHARMACY MARKET BY PRODUCT TYPE 2022-2028 ($ BILLION)
TABLE 38 EU-4 & UK E-PHARMACY MARKET BY PRODUCT TYPE 2022-2028 (%)
TABLE 39 SOME LEADING E-PHARMACIES IN GERMANY (2023)
TABLE 40 SOME LEADING ONLINE PHARMACIES IN ITALY
TABLE 41 SOME LEADING E-PHARMACIES IN SPAIN (2022)
TABLE 42 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY MEDICINE TYPE 2022-2028 ($ BILLION)
TABLE 43 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY MEDICINE TYPE 2022-2028 (%)
TABLE 44 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PLATFORM 2022-2028 ($ BILLION)
TABLE 45 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PLATFORM 2022-2028 (%)
TABLE 46 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY AGE GROUP 2022-2028 ($ BILLION)
TABLE 47 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY AGE GROUP 2022-2028 (%)
TABLE 48 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PRODUCT TYPE 2022-2028 ($ BILLION)
TABLE 49 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PRODUCT TYPE 2022-2028 (%)
TABLE 50 CONSUMER OPINIONS ON ONLINE SALES OF MEDICINE BY AGE GROUP IN RUSSIA: 2020-2021 (%)
TABLE 51 TOP FIVE PRESCRIPTION DELIVERY APPS & WEBSITES: SWITZERLAND
TABLE 52 COMPARISON OF E-PHARMACY MARKET IN NORDIC COUNTRIES
TABLE 53 INTERNET PENETRATION IN NORDIC COUNTRIES
TABLE 54 NORDIC COUNTRIES E-PHARMACY MARKET BY MEDICINE TYPE 2022-2028 ($ BILLION)
TABLE 55 NORDIC COUNTRIES E-PHARMACY MARKET BY MEDICINE TYPE 2022-2028 (%)
TABLE 56 NORDIC COUNTRIES E-PHARMACY MARKET BY PLATFORM 2022-2028 ($ BILLION)
TABLE 57 NORDIC COUNTRIES E-PHARMACY MARKET BY PLATFORM 2022-2028 (%)
TABLE 58 NORDIC COUNTRIES E-PHARMACY MARKET BY AGE GROUP 2022-2028 ($ BILLION)
TABLE 59 NORDIC COUNTRIES E-PHARMACY MARKET BY AGE GROUP 2022-2028 (%)
TABLE 60 NORDIC COUNTRIES E-PHARMACY MARKET BY PRODUCT TYPE 2022-2028 ($ BILLION)
TABLE 61 NORDIC COUNTRIES E-PHARMACY MARKET BY PRODUCT TYPE 2022-2028 (%)
TABLE 62 NORWAY: OVERVIEW OF ONLINE SALE OF MEDICINES
TABLE 63 CURRENT MARKET LANDSCAPE OF E-PHARMACY IN NORWAY
TABLE 64 TRADITIONAL PHARMACY & E-PHARMACY SERVICES MARKET SHARE IN ICELAND
TABLE 65 EUROPE E-PHARMACY MARKET BY REGION 2022-2028 ($ BILLION)
TABLE 66 EUROPE E-PHARMACY MARKET BY REGION 2022-2028 (%)
TABLE 67 EUROPE E-PHARMACY MARKET BY MEDICINE TYPE 2022-2028 ($ BILLION)
TABLE 68 EUROPE E-PHARMACY MARKET BY MEDICINE TYPE 2022-2028 (%)
TABLE 69 EUROPE E-PHARMACY MARKET BY PLATFORM 2022-2028 ($ BILLION)
TABLE 70 EUROPE E-PHARMACY MARKET BY PLATFORM 2022-2028 (%)
TABLE 71 EUROPE E-PHARMACY MARKET BY AGE GROUP 2022-2028 ($ BILLION)
TABLE 72 EUROPE E-PHARMACY MARKET BY AGE GROUP 2022-2028 (%)
TABLE 73 EUROPE E-PHARMACY MARKET BY PRODUCT TYPE 2022-2028 ($ BILLION)
TABLE 74 EUROPE E-PHARMACY MARKET BY PRODUCT TYPE 2022-2028 (%)
TABLE 75 EU-4 & UK E-PHARMACY MARKET BY MEDICINE TYPE 2022-2028 ($ BILLION)
TABLE 76 EU-4 & UK E-PHARMACY MARKET BY MEDICINE TYPE 2022-2028 (%)
TABLE 77 EU-4 & UK E-PHARMACY MARKET BY PLATFORM 2022-2028 ($ BILLION)
TABLE 78 EU-4 & UK E-PHARMACY MARKET BY PLATFORM 2022-2028 (%)
TABLE 79 EU-4 & UK E-PHARMACY MARKET BY AGE GROUP 2022-2028 ($ BILLION)
TABLE 80 EU-4 & UK E-PHARMACY MARKET BY AGE GROUP 2022-2028 (%)
TABLE 81 EU-4 & UK E-PHARMACY MARKET BY PRODUCT TYPE 2022-2028 ($ BILLION)
TABLE 82 EU-4 & UK E-PHARMACY MARKET BY PRODUCT TYPE 2022-2028 (%)
TABLE 83 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY MEDICINE TYPE 2022-2028 ($ BILLION)
TABLE 84 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY MEDICINE TYPE 2022-2028 (%)
TABLE 85 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PLATFORM 2022-2028 ($ BILLION)
TABLE 86 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PLATFORM 2022-2028 (%)
TABLE 87 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY AGE GROUP 2022-2028 ($ BILLION)
TABLE 88 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY AGE GROUP 2022-2028 (%)
TABLE 89 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PRODUCT TYPE 2022-2028 ($ BILLION)
TABLE 90 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PRODUCT TYPE 2022-2028 (%)
TABLE 91 NORDIC COUNTRIES E-PHARMACY MARKET BY MEDICINE TYPE 2022-2028 ($ BILLION)
TABLE 92 NORDIC COUNTRIES E-PHARMACY MARKET BY MEDICINE TYPE 2022-2028 (%)
TABLE 93 NORDIC COUNTRIES E-PHARMACY MARKET BY PLATFORM 2022-2028 ($ BILLION)
TABLE 94 NORDIC COUNTRIES E-PHARMACY MARKET BY PLATFORM 2022-2028 (%)
TABLE 95 NORDIC COUNTRIES E-PHARMACY MARKET BY AGE GROUP 2022-2028 ($ BILLION)
TABLE 96 NORDIC COUNTRIES E-PHARMACY MARKET BY AGE GROUP 2022-2028 (%)
TABLE 97 NORDIC COUNTRIES E-PHARMACY MARKET BY PRODUCT TYPE 2022-2028 ($ BILLION)
TABLE 98 NORDIC COUNTRIES E-PHARMACY MARKET BY PRODUCT TYPE 2022-2028 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security